Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (18445)	4/1/1998 3:19:00 PM
From: Mudcat	Respond to of 32384

1997 Seragen financials: biz.yahoo.com

To: Flagrante Delictu who wrote (18445)	4/2/1998 12:50:00 PM
From: Peter Silsbee	Read Replies (2) \| Respond to of 32384

Not to say that I'm excited about the compound, but... "Preliminary statistical analysis of the trial results indicate that the TRUE response rate, based on a 95% confidence interval, lies BETWEEN 18 & 41%." They don't know? The "true" response rate can never be known, without testing an infinite number of patients. That's why they use confidence intervals. If someone tells you they have a drug with a "true" response rate of 80%, with no margin for error, run. Having said that, there's a big difference between 18 and 41, and a roughly 1 in 40 chance that the response rate is less than 18. And, I pretty much agree with your other comments. PLS